I-Ying Chen

I-Ying Chen

Auto-generated profile, based on publicly available information

I-Ying Chen

Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Veterinary Anaesthesia and Analgesia
Verified
Journal Article
Closed access
ICI-Ying Chen
I-Ying Chen
HTHaruka Tamogi
Haruka Tamogi
YWYixian Wei
Yixian Wei
KKKeiko Kato
Keiko Kato
TITakaharu Itami
Takaharu Itami
KYKazuto Yamashita
Kazuto Yamashita

21 October 2026 in American Journal of Veterinary Research
Verified
Journal Article
Open access
RCRai-Ning Chang
Rai-Ning Chang
HWHsien-Chi Wang
Hsien-Chi Wang
CCChao-Chin Chang
Chao-Chin Chang
ICI-Ying Chen
I-Ying Chen
Objective: To investigate the efficacy of 2 mg/kg sugammadex in reversing moderate rocuronium-induced neuromuscular blockade (NMB) in dogs, focusing on recovery time and recurarization. Methods: In this prospective, nonrandomized, unblinded experimental study, 12 healthy adult mixed-breed dogs were evaluated before elective surgery and assigned to a control group (spontaneous recovery; n = 6) or a reversal group (2 mg/kg sugammadex; n = 6). Anesthesia was induced with propofol and maintained with isoflurane without premedication. Neuromuscular function was monitored using train-of-four (TOF) acceleromyography. Moderate NMB was defined as TOF count 1 to 3, and complete NMB recovery was defined as a normalized TOF ratio (TOFR; measured TOFR/baseline TOFR) ≥ 0.9. Rocuronium (0.6 mg/kg IV) was administered, followed in the reversal group by sugammadex (2 mg/kg IV) at first-twitch (T1) reappearance. Dogs in the reversal group were monitored for 60 minutes after complete NMB recovery. Recovery time was defined as T1 reappearance to normalized TOFR ≥ 0.9; recurarization was defined as a subsequent decrease in normalized TOFR to < 0.9 after complete NMB recovery. Results: Recovery time was significantly shorter in the reversal group (median [range], 1.3 [0.8 to 3.0] minutes) than in the control group (18.6 [12.3 to 35.5] minutes). No recurarization was observed. Conclusions: Sugammadex at 2 mg/kg provided rapid reversal of moderate rocuronium-induced NMB in isoflurane-anesthetized dogs. No recurarization was observed during the 60-minute monitoring period after complete NMB recovery. Clinical Relevance: Sugammadex at 2 mg/kg may be considered for reversal of moderate rocuronium-induced NMB at T1 reappearance in dogs. However, objective neuromuscular monitoring remains essential to guide reversal decisions and confirm neuromuscular recovery.